Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Jianhua Luo

Jianhua Luo

Director, USA USA

George Vasmatzis

George Vasmatzis

Co-Director, USA USA

Shidong Jia

Shidong Jia

Founder & CEO, USA USA

Peter Schulz-Knappe

Peter Schulz-Knappe

Chief Scientific Officer, Germany Germany

Qing Kay Li

Qing Kay Li

Associate Professor, USA USA

Harish C. Pant

Harish C. Pant

Senior Investigator USA USA

David Ge

David Ge

CEO & President USA USA



Total Clinical Trial Management USA USA

Biomarkers Congress-2019

About Conference

With Immense pleasure Biomarkers Congress-2019 invites all the participants across the globe to attend the “International Conference on Biomarkers and Clinical Research” during January 21-22, 2019 at Dubai, UAE. Biomarkers Congress-2019 will uncover different facets of Biomarker study from research to therapy and its applications in divergent fields of Clinical Sciences.

Biomarkers Congress-2019 is organized around the theme: “Awareness of Biomarkers & Clinical Research”.

This conference aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Biomarkers and Clinical Research. Biomarkers have the extra potential to identify individuals susceptible to particular diseases. Biomarkers Congress-2019, in the hands of clinical investigators, provide a dynamic and powerful approach to understanding the spectrum of diseases with obvious applications in analytic epidemiology, biomarkers and clinical research in disease prevention, diagnosis and disease management. The cancer biomarker conferences are very much invigorated to extend the knowledge of continuous exposes and scientific research updates in these days. All advances can be evidenced in this biomarker congress.

International Conference on Biomarkers and Clinical Research conference will be organized by ME Conferences which is comprised of 3000+ international Events with over 2000+ Conferences, 1200+ Symposiums and Workshops on multiple fields of clinical, medical, Pharmaceutical, Engineering, Science, Technology, and Business..

We look forward to an exciting 2-day scientific event, business meeting, trade fair and exhibition in the alluring city of Dubai, UAE.

Why attend???

  • To ease opportunities for networking, collaboration and exchange of ideas with globally distinguished leaders in Biomarkers research.
  • To categorize research and practice-based innovations in optimizing Clinical research and Biomarkers development.
  • To discuss and deliberation the challenges and prospects in the new era of optimizing Clinical research and development reforms.
  • To dispute gaps and priorities for sustainable development in optimizing Biomarkers research and development.
  • To recognize opportunities for evidence-based practice in optimizing Biomarkers research and development.

Who Can Attend?

Oncologists, Radiologists, Hematologists, Immunologists, Neurologists, Cardiologists, Physicians, Geneticists, Psychiatrists, Pathologists, Nurses, Medical Students, Clinical Researchers, Cancer Researchers, Molecular Biologists, Nutritionists, Young Researchers, Bioinformaticians, Medical Devices Specialist, Medical Faculty, Business Entrepreneurs, Data Management Professionals, Pharma Experts, Diagnostics Experts


Track: Biomarkers

Biomarker is a key molecular or cellular event that links a specific environmental exposure to a health outcome. Biomarkers can be everything that can be correctly measured as an indicator of normal biological functioning, pathogenic paths or a drug response to a therapeutic drug intervention. Biomarkers play a vital role in understanding the relationships between exposure to environmental chemicals, the development of chronic human diseases, and the identification of subgroups that are at increased risk for disease. Biomarkers are used in many specific fields.

a.       Medicine

b.      Regulatory validation

c.       Cell biology

d.      Geology and astrobiology

e.       Ecotoxicology

Track: Clinical Biomarkers

Biomarkers which are used for clinical resolutions are called clinical biomarkers. Clinical biomarkers along with providing an effervescent and significant methodology to understanding the range of many diseases with uses in judgmental and analytic epidemiology, arbitrary clinical trials, screening for drugs or disease diagnosis and prognosis. Well-defined as changes in the constituents of cells or body fluids, these clinical biomarkers offer the means for standardized classification of a disease and risk factors, and the can spread the base information about the underlying pathogenesis of a disease. The main studies in clinical biomarkers are done in the fields of oncology, drug discovery, disease diagnostics and pharmacogenomics.

Track: Advance Biomarker Research and Testing

Biomarker testing is a collection of tests that looks for the molecular signs of health so that doctors can plan the best care. Biomarker testing can also be called as genetic testing or biomarkers testing.  Biomarkers, a foundation of precision oncology, are very important in management of breast cancer, gastro-esophageal cancer and non-small cell lung cancer.

The major goal of Advances in Biomarker Sciences and Equipment is to accelerate the clinical application of biomarker-based methods to address important challenges in screening, diagnosis, and disease management.

The advances in biomarker testing are mainly in the fields of genetic testing, cancers and other diseases in their diagnosis, treatment and imaging. Testing practices are intensely deliberated, influencing the diagnostic quality and affecting pathologists, oncologists and patients.

Track: Cardiac Biomarkers

Cardiac markers are measured biomarkers to assess cardiac function. They are often discussed in the context of myocardial infarction, but other conditions can lead to an elevation in the level of the cardiac marker. Cardiac biomarkers are elements that are released into the blood when the heart is damaged or strained. Cardiac marker is used in the identification and risk stratification of patients with chest pain and suspected acute coronary syndrome (ACS). These markers include enzymes, hormones and proteins. Cardiac biomarkers have evolved as essential tools in cardiology in the last 50 years, that is, for primary and secondary prevention, the diagnosis and treatment of acute myocardial infarction (AMI), and the diagnosis and stratification of the risk of heart failure.

Track: Genomic Biomarkers

Current genomics and biotechnology promise the development of biomarkers to a state to predict the risk of individual disease that allows early detection of the disease and improves diagnostic classification to better inform individualized treatment. Biomarkers are biological measurements that can be used to predict the risk of diseases, to allow early detection of diseases, to improve the selection of treatment and to monitor the outcome of therapeutic interventions. The main objective of the Human Genome Project was the identification and development of such biomarkers for "personalized, preventive and predictive medicine".

Track: Neurological Biomarkers

Neurological biomarkers are present in the CSF (cerebrospinal fluid), but only at or imperceptibly in the blood. The brain is carefully protected by the blood-brain barrier, which protects it from harmful elements that flow into the bloodstream. Unfortunately for diagnostic purposes, this barricade has also made brain chemistry unattainable for proper blood testing. Neurological biomarkers can be studied using CSF, but this requires an invasive and painful lumbar puncture technique.

Track: Biomarkers in Drug Discovery & Development

Biomarkers have various uses in pharmaceutical R & D. With the current introduction of high-performance instrumentation, protein and gene arrays and bioinformatics, clinical decisions like Drug development and choosing the type of treatment can be made efficiently. Still, there is a deficiency of effective biomarkers to increase the drug development from pre-clinical through all levels of clinical studies. Biomarker in Drug Discovery can also lead to the growth of Modified Medicines.

Track: Immunological Biomarkers

Biomarkers that can control various diseases of the immune system such as autoimmunity, immunodeficiency, cancer, allergies and infections are called immunological biomarkers. As the immune system interacts with all other systems in the body, it plays a very important role in the discovery of biomarkers. Immunological biomarkers, such as miRNA and serum Biomarkers can provide information about the immune response of a body under normal or abnormal conditions.

Track: Biomarkers in Pharmacology

Biomarkers are important tools in drug development and pharmaceutical research. Biomarkers have been recognized by making the drug development process more efficient and have become an essential part of a pharmaceutical and pharmacological research. It is expected that the number of biomarkers will ultimately transition into the clinical laboratory.

The biomarkers demonstrate the dose-response relationships of the drug between changes in biomarkers, the onset of the injury and the severity of the injury corresponding to the progression of the injury.

Track: Biomarkers in Oncology

Biomarkers play an important role in oncology that is used in clinical research for risk assessment, differential diagnosis, determination of the nature of tumors, for detection purposes, to determine the prognosis and dose-response of the drug to the treatment. The process indicative of the presence of cancer in the body is carried out by means of tools known as cancer biomarkers. There are different types of cancer in which biomarkers have their application, such as lung, melanoma, breast, colorectal, pancreas and many more. Biochemically, cancer biomarkers can be DNA, RNA, proteins, peptides, hormones, metabolites and even biological processes such as apoptosis, angiogenesis or proliferation. There are three main types of cancer biomarkers depending on their clinical use: prognostic, predictive and pharmacodynamics markers.

Track: Clinical Research

Clinical research is a branch of social security science that decides the well-being and adequacy (viability) of the solutions, devices, analytical elements and treatment regimes foreseen for human use. These could be used for counterproductive action, treatment, findings or to calm the side effects of some diseases. Clinical research is exclusive in relation to clinical practice. Accumulated medications are used in clinical practice, while in clinical research confirmation is gathered to set up a treatment.

Track: Clinical Trials

Clinical trials are tests performed in clinical research. Such imminent thoughts of biomedical or behavioral research in human members are intended to answer particular queries regarding biomedical or behavioral mediations, including new medications (eg. new antibodies, medications, dietary decisions, dietary supplements and medical devices) and intercessions. Known that require studies and exams. Clinical trials produce information on safety and viability.

Market Analysis Report

Importance & Scope:

The biomarker market presents the greatest of all opportunities in sub-segments of representative diseases. This study investigates one of the most important motors of the market: the introduction of combination therapies, which are expected to continue contributing substantially to the market growth during the forecast period. This report analyzes emerging markets by disease segment. Continuous growth is expected in emerging geographies, driven by the growing middle class in emerging countries such as India, China, Brazil and Russia. This report seeks to address issues of critical importance to analyze a changing market dynamics, emerging players and technologies, strategies to access emerging markets and specific disease segments and geographies to allocate resources and make effective decisions. For companies with an effective strategy, the market opportunity awaits you. It is important to emphasize that the ability to develop an effective strategy begins with the place where the opportunity exists and ends with the way to execute effectively to obtain the opportunity's profits.

Why Dubai?

Biomarkers Congress-2019 will be held in Dubai. Dubai has emerged as a global city and a Middle East business center. Dubai ranked 44th among the best financial cities in the world and the 27th richest city in the world in 2012. It is also an international financial center and ranks 37th among the 50 most important financial cities in the world and the first in the Middle East. According to a research report on the future competitiveness of cities, by 2025, Dubai will have risen to 23rd in the index. Cancer research is being conducted mainly in Asian countries near Dubai, making it an appropriate destination for oncology and cancer conferences.

Conference Highlights

  • Biomarkers
  • Clinical Biomarkers
  • Advance Biomarker Research and Testing
  • Cardiac Biomarkers
  • Genomic Biomarkers
  • Neurological Biomarkers
  • Immunological Biomarkers
  • Biomarkers in Pharmacology
  • Biomarkers in Drug Discovery & Development
  • Clinical Research
  • Biomarkers and Nanoparticles

Global market analysis:

The market for biomarker technologies is entrusted to reach USD 74.51 billion for 2022 from USD 46.97 billion in 2017, at a compound annual rate of 9.7% during the foreseen time frame.

Depending on the type of product, the market for biomarker technologies is divided into instruments, services and programming/information technology. In 2018, the consumables part was relied on to represent the largest market share due to its higher sales volume compared to the instruments. The consumables market is further fragmented into kits, reagents and chromatography columns. In 2018, the kits and reagents segments represented the largest in the consumables market.

Although critical advances have been made in the area of biomarkers, interpreting them invaluable clinical trials is sad and a major obstacle to the clinical use of these biomarkers. The development of this market is driven by factors such as the expansion of health spending, the increase in R & D funding, the increase in the usefulness of biomarkers for diagnostic purposes and the increase in the research of biomarkers.

In 2017, North America represented the largest share in the biomarker market. The Asia Pacific recorded the highest development from 2017 to 2022 for the biomarker advances to market. Factors such as the increasing rate of malignancy, the development of the geriatric population and the support of private and public associations for biomarker research are driving the development of this regional section. By shaping innovation, the biomarker breakthrough market is characterized by immunoassays, PCR, mass spectrometry, NGS, chromatography, cytogenetic and other different advances. The immunoassay portion accounted for most of it in 2017. This section is further classified into ELISA, western blot and protein microarrays. In 2017, the ELISA segment represented the largest share in the immunoassay market.

Statistical analysis of members associated with Biomarkers

Market Analysis of Biomarkers by Region

Biomarkers Technologies Market, By Research Area:
  • Proteomics
  • Genomics
  • Metabolomics
  • Lipidomics
  • Other research types

Major associations around the world

  • Biomarkers society
  • The Biomarker consortium
  • International society for oncology and Biomarkers
  • Biomarkers profile corporation
  • World molecular imaging society
  • European society of molecular imaging
  • Society of nuclear medicine and molecular imaging

Universities associated with Biomarkers

Top Universities in UAE
  • Dubai Medical College for Girls
  • Gulf Medical University Ajman
  • United Arab Emirates University
  • University of Sharjah
  • Ras al-Khaimah Medical and Health Sciences University
  • King Fahad Medical City
  • Tabuk University
  • King Saud bin Abdulaziz University for Health Sciences

Related Conferences:

Related Societies:  

Clinical Research & Biomarkers Societies in USA:

ACRP: Association of Clinical Research Professionals  | American Association for Cancer Research  | American Cancer Society  | American Cancer Society  | American Cancer Society Cancer Action Network  | American Federation for Medical Research: AFMR  | American Society of Clinical Oncology   | American Society of Clinical Oncology | ASCO  | Anxiety and Depression Association of America, ADAA  | Association of Clinical Research Organizations  | Association-Clinical Research | CGD Society - Clinical trials  | Clinical Research Association of Canada  | Clinical Trials - Alzheimer's Association  | Clinical Trials - MPS Society  | Clinical Trials – Society for Women's Health Research  | American Thyroid Association  | Clinical Trials | Leukemia and Lymphoma Societ  | Clinical Trials | National CML Society | Clinical Trials Veterinary Cancer Society  | Clinical Trials Network | Clinical Trials: American Diabetes Association  | CRS : Clinical Research Society | DIA - Clinical Research - Drug Information Association  | Dysphagia Research Society  | Dystonia Medical Research Foundation | DMRF  | International Association of Clinical Research Nurses  | National Brain Tumor Society  | Osteoarthritis Research Society International (OARSI)  | Society for Clinical Data Management (SCDM)  | Society for Clinical Trials (SCT)  | SOCRA The Society of Clinical Research Associates  | T21RS  | The American Society of Hematology  | USA & Canada - Society of Clinical Research Associates  | American Association for Cancer Research  | American Breast Cancer Foundation

Clinical Research & Biomarkers Societies in Europe:

The European Association for Clinical Pharmacology and Therapeutics (EACPT)   | Academy of Physicians in Clinical Research  | Association of European Cancer Leagues (ECL) | Association of Medical Research Charities: AMRC  | Breast International Group (BIG) | Cardiovascular and Interventional Radiological Society of Europe (CIRSE) | DIA - Clinical Research - Drug Information Association  | EACR - European Association for Cancer Research  | ECFS Clinical Trials Network  | ECRIN: Facilitating European Clinical Research  | ENGOT  | ESA Clinical Trial Network  | ESCMID  | ESDR: European Society for Dermatological Research  | ESMO: European Society for Medical Oncology  | ESPR European Society for Paediatric Research   | European Association for Cancer Research (EACR) | European Association of Neuro-Oncology (EANO) | European Association of Nuclear Medicine (EANM) |European Association of Urology (EAU) | European CanCer Organisation: ECCO  | European Oncology Nursing Society (EONS) | European Organisation for Research and Treatment of Cancer (EORTC) | European School of Oncology (ESO) | European Sleep Research Society   | European Society for Clinical Investigation

Clinical Research & Biomarkers Societies in Middle-East:

 Moazzara – Emirates Association for Cancer Support| Angels of Mercy Cancer Society | Friends of Cancer Patients SocietyAssociation for Molecular Pathology| Middle-Eastern Association for Cancer Research (MEACR) |  Iranian Cancer Association (ICA) |Iranian Society of Medical Oncology and Hematology (ISMOH)| Indonesian Association of Clinical Pathology and Laboratory Medicine |Romanian Society of Biochemistry and Molecular Biology |Romanian Society of Human Genomics | The Malaysian Biochemical SocietyIranian Society of Clinical Oncology (ISCO) |  Pakistan Society of Clinical Oncology (PSCO)

Clinical Research & Biomarkers Societies in Asia Pacific:

Association of Oncologists of Uzbekistan |  Chinese Society of Clinical Oncology (CSCO) |  Hong Kong Cancer Therapy SocietyIndian society clinical researchIndian Society of Medical & Paediatric Oncology (ISMPO) |  Indonesian Society of Hematology and Medical Oncology (ISHMO) |Japan Society of Clinical Oncology (JSCO) |  Japanese Society of Medical Oncology (JSMO) |  Korean Association for Clinical Oncology (KACO) |  Malaysian Oncological SocietyMedical Oncology Group of Australia (MOGA) |  Myanmar Oncology SocietyNew Zealand Association of Clinical ResearchNew Zealand Society for Oncology (NZSO) |  Oncology Club, BangladeshPhilippine Society of Medical Oncology (PSMO) |  Singapore Society of Oncology (SSO) |  Taiwan Oncology Society (TOS) |  Thai Society of Clinical Oncology (TSCO)


Past Conference Report

Biomarkers Congress 2017

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date January 21-22, 2019

For Sponsors & Exhibitors

Speaker Opportunity

Past Conference Report

Supported By

Biomarkers Journal Journal of Molecular Biomarkers & Diagnosis Journal of Cancer Science & Therapy Journal of Carcinogenesis & Mutagenesis

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


  • Alzheimer's Disease
  • Autoimmune Disease
  • Bio Indicator
  • Bio Pharm
  • Biochemistry
  • Biomarker Discovery
  • Biomarker Discovery
  • Biomarkers
  • Breast Cancer Biomarkers
  • Cancer Bioinformatics
  • Cancer Biology
  • Cancer Biology
  • Cancer Biomarkers
  • Cancer Biomarkers
  • Cancer Research
  • Cancer Research
  • Cancer Therapy
  • Cardiovascular Disease
  • Cell Biology
  • Cell Signalling
  • Clinical Therapeutics
  • Cytogenetic Biomarkers
  • Data Analysis
  • Diagnostics
  • Drug Designing
  • Drug Dicovery
  • Drug Discovery
  • Ecotoxicology
  • Environmental Pharmacology
  • Epigenetics
  • Genetics
  • Geology And Astrobiology
  • Imaging Biomarker
  • Immunological Disorders
  • Immunology
  • Immunotherapy
  • Internal Medicine
  • Lung Cancer Biomarkers
  • Medical Imaging
  • Metabolite
  • Molecular Biology
  • Molecular Biomarkers
  • Molecular Modelling
  • Molecular Pathology
  • Molecular Structure
  • Neurological Disorders
  • Pathology
  • Personalized Medicine
  • Pharmacogenomics
  • Pharmacology
  • Prostate Cancer Biomarkers
  • Psychology
  • Saliva Testing
  • Sponge Biomarkers
  • Therapeutic
  • Translational Research
  • Tumor Markers